Compare IOVA & PAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IOVA | PAX |
|---|---|---|
| Founded | 2007 | 1988 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 2.2B |
| IPO Year | 2008 | 2020 |
| Metric | IOVA | PAX |
|---|---|---|
| Price | $3.77 | $13.04 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 2 |
| Target Price | $9.00 | ★ $18.00 |
| AVG Volume (30 Days) | ★ 13.1M | 846.5K |
| Earning Date | 05-07-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 4.65% |
| EPS Growth | ★ 14.84 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $51.55 | $13.00 |
| Revenue Next Year | $37.55 | $15.87 |
| P/E Ratio | ★ N/A | $25.65 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.64 | $9.63 |
| 52 Week High | $5.63 | $17.80 |
| Indicator | IOVA | PAX |
|---|---|---|
| Relative Strength Index (RSI) | 52.44 | 62.44 |
| Support Level | $2.02 | $12.81 |
| Resistance Level | $4.34 | $14.53 |
| Average True Range (ATR) | 0.30 | 0.40 |
| MACD | 0.02 | 0.16 |
| Stochastic Oscillator | 51.69 | 98.32 |
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.
Patria Investments Ltd is an alternative asset management firm specializing in resilient sectors across select regions. It seeks to provide world-wide and Latin American investors with attractive investment products that allows portfolio diversification and consistent returns. The group promotes inclusive and sustainable development in the Asset Classes: Private Equity, Private Equity Solutions, Credit, Real Estate, Infrastructure, and Public Equities Main sectors: Agribusiness, Power & Energy, Healthcare, Logistics & Transportations, Food & Beverage and Digital & Tech Services Investment Regions.